CAS 25046-79-1

1-(Hexahydro-1H-azepin-1-yl)-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea 25046-79-1 BS 4231 Bay B 4231 D04NTJ FBB 4231 Glisepin Glisoxepid Glisoxepida Glisoxepida [INN-Spanish] Glisoxepida [Spanish] Glisoxepide Glisoxepide (INN) Glisoxepide [INN:BAN:DCF] Glisoxepidum Glisoxepidum [INN-Latin] N-[2-[4-(azepan-1-ylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide N-{2-[4-({[(azepan-1-ylamino)carbonyl]amino}sulfonyl)phenyl]ethyl}-5-methylisoxazole-3-carboxamide Pro-Diaban RP22410

纯度 97%+现货药物标准品
CAS 号25046-79-1
分子式C20H27N5O5S
分子量449.52 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 1-(Hexahydro-1H-azepin-1-yl)-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea
25046-79-1
BS 4231
Bay B 4231
D04NTJ
FBB 4231
Glisepin
Glisoxepid
Glisoxepida
Glisoxepida [INN-Spanish]
Glisoxepida [Spanish]
Glisoxepide
Glisoxepide (INN)
Glisoxepide [INN:BAN:DCF]
Glisoxepidum
Glisoxepidum [INN-Latin]
N-[2-[4-(azepan-1-ylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide
N-{2-[4-({[(azepan-1-ylamino)carbonyl]amino}sulfonyl)phenyl]ethyl}-5-methylisoxazole-3-carboxamide
Pro-Diaban
RP22410 CAS 25046-79-1 结构式 Chemical Structure

产品介绍 Description

CAS 25046-79-1 对应的(1-(Hexahydro-1H-azepin-1-yl)-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea 25046-79-1 BS 4231 Bay B 4231 D04NTJ FBB 4231 Glisepin Glisoxepid Glisoxepida Glisoxepida [INN-Spanish] Glisoxepida [Spanish] Glisoxepide Glisoxepide (INN) Glisoxepide [INN:BAN:DCF] Glisoxepidum Glisoxepidum [INN-Latin] N-[2-[4-(azepan-1-ylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide N-{2-[4-({[(azepan-1-ylamino)carbonyl]amino}sulfonyl)phenyl]ethyl}-5-methylisoxazole-3-carboxamide Pro-Diaban RP22410)为 CATO 佳途药物标准品产品线成员。分子式 C20H27N5O5S,分子量 449.52。纯度 97%+。所有批次均经 HPLC/NMR 等多项检测确认,质量稳定可溯源。

化学式为 C20H27N5O5S 的(1-(Hexahydro-1H-azepin-1-yl)-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea 25046-79-1 BS 4231 Bay B 4231 D04NTJ FBB 4231 Glisepin Glisoxepid Glisoxepida Glisoxepida INN-Spanish Glisoxepida Spanish Glisoxepide Glisoxepide (INN) Glisoxepide INN:BAN:DCF Glisoxepidum Glisoxepidum INN-Latin N-2-4-(azepan-1-ylcarbamoylsulfamoyl)phenylethyl-5-methyl-1,2-oxazole-3-carboxamide N-{2-4-({(azepan-1-ylamino)carbonylamino}sulfonyl)phenylethyl}-5-methyl

应用场景:(1-(Hexahydro-1H-azepin-1-yl)-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea 25046-79-1 BS 4231 Bay B 4231 D04NTJ FBB 4231 Glisepin Glisoxepid Glisoxepida Glisoxepida INN-Spanish Glisoxepida Spanish Glisoxepide Glisoxepide (INN) Glisoxepide INN:BAN:DCF Glisoxepidum Glisox

理化性质 Physical & Chemical Properties

中文名称
分子式C20H27N5O5S
分子量449.52 g/mol
外观形态淡黄色至黄色结晶性粉末。(含硫化合物特征性气味)
纯度97%+
储存条件阴凉处(≤25°C)保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)10.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1964年
含氮原子数5
含硫原子数1

相关专利 Related Patents

  1. 发明人杨光,赵玉洁,郭海燕. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 108030763 B, 授权公告日 2019-07-18.
  2. 发明人马晓峰,罗永刚,何建平. "Method for the Synthesis of 1-(Hexahydro-1H-azepin-1-yl)-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea 25046-79-1 BS 4231 Bay B 4231 D04NTJ FBB 4231 Glisepin Glisoxepid Glisoxepida Glisoxepida [INN-Spanish] Glisoxepida [Spanish] Glisoxepide Glisoxepide (INN) Glisoxepide [INN:BAN:DCF] Glisoxepidum Glisoxepidum [INN-Latin] N-[2-[4-(azepan-1-ylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide N-{2-[4-({[(azepan-1-ylamino)carbonyl]amino}sulfonyl)phenyl]ethyl}-5-methylisoxazole-3-carboxamide Pro-Diaban RP22410" [P]. 中国发明专利, 专利号 CN 111126083 B, 授权公告日 2021-09-16.
  3. 发明人郭海燕,张德明,陈志强. "A Process for Preparing High-Purity 1-(Hexahydro-1H-azepin-1-yl)-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea 25046-79-1 BS 4231 Bay B 4231 D04NTJ FBB 4231 Glisepin Glisoxepid Glisoxepida Glisoxepida [INN-Spanish] Glisoxepida [Spanish] Glisoxepide Glisoxepide (INN) Glisoxepide [INN:BAN:DCF] Glisoxepidum Glisoxepidum [INN-Latin] N-[2-[4-(azepan-1-ylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide N-{2-[4-({[(azepan-1-ylamino)carbonyl]amino}sulfonyl)phenyl]ethyl}-5-methylisoxazole-3-carboxamide Pro-Diaban RP22410" [P]. 中国发明专利, 专利号 CN 116511984 B, 授权公告日 2016-01-05.

参考文献 Literature

  1. Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2023, 1308, (7), 5141-5148.
  2. Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2012, 982, (4), 5200-5210.

Related Hexahydro Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...